Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1838-1846

  Yu, Joanne L ^a   Rak, Janusz W ^a   Klement, Giannoula ^a   Kerbel, Robert S ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; TUMOR BLOOD FLOW; TUMOR GROWTH;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MELANOMA; MICE; MICE, SCID; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037086082     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Vascular permeability factor (VPF, VEGF) in tumor biology
2. Vascular permeability factor, an endothelial cell mitogen related to PDGF
3. The biology of vascular endothelial growth factor
4. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice
5. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
6. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
7. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect
8. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
9. Different signal transduction properties of KDR and Fltl. two receptors for vascular endothelial growth factor
10. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
11. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
12. Identification of a 190-kDa vascular endothelial growth factor 165 cell surface binding protein on a human glioma cell line
13. The VEGF splice variants: Properties, receptors, and usage for the treatment of ischemic diseases
14. Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon
15. Differential expression of VEGF isoforms in mouse during development and in the adult
16. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues
17. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
18. Vascular endothelial growth factor (VEGF) and melanoma. N-acetylcysteine down-regulates VEGF production in vitro
19. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells
20. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
21. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg. AC transgenic mice and FVB/N mice
22. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase
23. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
24. The dormant in vivo phenotype of early stage primary human melanoma: Termination by overexpression of vascular endothelial growth factor
25. Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenicity
26. Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine resistant phenotype
27. Human melanoma: Development and progression
28. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
29. Coexpression of VEGF receptors VEGF-R2 and neuropilin-I in proliferative diabetic retinopathy
30. Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice
31. Openings between defective endothelial cells explain tumor vessel leakiness
32. Scanning electron microscopy of vascular corrosion casts-technique and applications: Updated review
33. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors
34. Mechanisms of angiogenesis and arteriogenesis
35. Evidence for characteristic vascular patterns in solid tumours: Quantitative studies using corrosion casts
36. Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study
37. Expression of vascular permeability factor/vascular endothelial growth factor melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
38. Angiogenic factors
39. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
40. 165
41. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
42. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature
43. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma
44. The vascularity of cutaneous melanoma: A quantitative histological study of lesions 0.85-125 mm thickness
45. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
46. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
47. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study
48. Relation of neovascularisation to metastasis of non-small-cell lung cancer
49. Extent of vascularization as an independent prognostic indicator in thin (0.76 mm) malignant melanomas
50. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin
51. Tumor hypoxia: Definitions and current clinical biologic, and molecular aspects
52. Heterogeneous vascular dependence of tumor cell populations
53. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer
54. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer
55. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma
56. 121-toxin conjugate: Differential effect on proliferating endothelial cells
57. Ribozyme approach to down-regulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC)